Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › BAJAJHCARE

BAJAJHCARE

Bajaj Healthcare Limited
Micro-capPharma ↗

What the six lenses say about BAJAJHCARE — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹328.8
2026-09-08
VWAP · 1Y anchor
₹372
-11.6% from VWAP
P/E · TTM
—
no TTM EPS
52-week range
23%
position low→high
RSI(14)
51
momentum

Own sector index

Pharma ↗
Overweight

1M

+0.4%

3M

+10.5%

1Y

+22.0%

Breadth >EMA21

56%

How BAJAJHCARE’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
6.0
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD23›

The actual numbers

Price vs VWAP (1y)-11.6%
EMA trend stackDown · 21<50<200
Price vs 200-EMA-7.5%
Price vs 50-EMA+0.4%
RSI(14)51
RS vs Nifty 500 · 3M+8.7%
RS vs sector · 3M+2.7%
52-week range23%
Volume vs 30d avg1.62×
Volume vs 60d avg0.37×
ATR(14) · volatility11.8
Bollinger width · vol contraction0.048
FundamentalD219›

The actual numbers

Return on equity (ROE)-0.6%
Operating margin5.2%
Net margin-0.3%
Revenue growth · YoY+4.8%
Debt / equity1.19×

Full 8-quarter history in the financials table below.

ValuationD1087›

The actual numbers

52-week range23%
CatalystD431›

The actual numbers

Earnings & momentum28
Capital actions10
Governance85

Every filing in the corporate-announcements panel below.

FlowD1060›

The actual numbers

Promoter holding58.3%
Delivery · 30d avg48.1%
Up/down-day asymmetry0.3pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D2 + D10 ) ÷ 2 = 6.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Below threshold
8
Conviction score 8/100 · avg-decile strength 6.0/10
Conviction score8/100›
TechnicalD2›
FundamentalD2›
ValuationD10›
CatalystD4›
FlowD10›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+2.8pp
-0.2pp
+3.4pp
+10.3pp
+5.2pp
-18.9pp
Nifty 500
Broad-market baseline
+2.7pp
-0.2pp
+2.3pp
+8.7pp
-0.5pp
-24.1pp
Sector
Own-sector index
—
—
-0.5pp
+2.7pp
-13.7pp
-44.9pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

BAJAJHCARE daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
328.80+7.35

Relative strength

RS vs baseline · rebased to 100

BAJAJHCARE ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
89.61+2.37

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

No quarterly financials available.

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 29 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 Aug '26
    LOWgovernance
    ESOP/ESOS/ESPS
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 Aug '26
    LOWgovernance
    Options to purchase securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Aug '26
    LOWgovernance
    Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Aug '26
    MEDIUMcapital
    Credit Rating- Revision
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 27 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 Jul '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 20 Jul '26
    LOWgovernance
    Statement of deviation(s) or variation(s) under Reg. 32
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 Jul '26
    LOWgovernance
    Monitoring Agency Report
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 Jul '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 Jul '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 16 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds BAJAJHCARE

Mutual funds holding BAJAJHCARE (1)

FundWeightAUM ₹crGrade
HDFC Pharma and Healthcare Reg Gr0.65%2,940

ETFs holding BAJAJHCARE (0)

No tracked ETF holds BAJAJHCARE ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma